- What is SourceGenerics?
- What is an Opportunity?
- View Opportunities
- Post Opportunities
What is an opportunity?
SourceGenerics showcases opportunities ranging from technology and product dossiers through to portfolios and businesses. And to make your life easier, SourceGenerics focuses on generics products - no more, no less. So whether you want to in-license, out-license, buy or sell opportunities, advertise your services or target the right people, then SourceGenerics is the solution.
Each business opportunity is expected to result in a separate business deal. If you want to strike more than one deal, then you should post a separate opportunity for each potential deal.
LICENSE - BUY - SELL
Opportunities in these segments
- Oral Solid-Dose Products
- Topical Products
- Injectable Products
- Other Finished-Dosage Forms
- Active Pharmaceutical Ingredients (APIs)
Types of opportunities
- Intellectual Property
- Distribution Rights
Einar Geir Hreinsson, Vice-President Strategic Projects at Actavis, says:
"We used this channel to reach potential customers and it turned out to be considerably more effective than we had expected. It is invaluable to be able to introduce a new project like Opening Pharma in this way, through a single portal with connections in all directions. This will be our first choice the next time we want to give a new project a good promotion."
Rich DiCicco, Chief Executive Officer of Harvest Moon Pharma, comments:
"Harvest Moon Pharma has listed its complex generics and biosimilars on SourceGenerics for three years. We have received enquiries from 206 companies - including Pfizer, Sanofi, Teva, Stada, Ranbaxy and Sandoz - from 58 countries, and we are very pleased with the results. We intend to keep listing on SourceGenerics indefinitely."
Sanjiv Puri, Chief Executive Officer of Australia's Generic Partners, tells us:
"Within a week of posting our business opportunities on SourceGenerics we had received over 10 quality enquiries from leading generics companies throughout the world."